4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-151300
SVP & Chief Scientific Officer sold 670 shares at $13.96 ($9,353)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-16 | Sale : show line 1 in the form | −670 | $13.96 | $9,353 | 18,265 | D |
| Open-market sales · 670 sh · avg $13.96 · $9,353 | ||||||
Loading xslF345X03/doc4.xml…